Kerry Stokes’ Media Executives Gain from Orthocell Interest
What explains Seven West Media’s strong focus on ASX medtech company Orthocell? Orthocell is a Perth-based, ASX-listed medical technology firm specializing in cell regeneration therapies. Founded in 2007 as a spin-out from the University of Western Australia, it currently holds a market capitalization around $300 million.
Over the past year, Orthocell’s value has increased by about 80%, marking it as a notably successful player among many smaller medtech companies on the ASX.
Most people wouldn’t have heard of Orthocell.
The company remains just one of several smaller medtech firms publicly traded in Australia, reflecting steady growth within this niche sector.
Subscribe to receive five free articles each month and follow topics, people, and companies critical to your interests.
Author's summary: Seven West Media’s notable attention to Orthocell highlights the rising value and impact of smaller medtech firms on the ASX, driven by innovation and steady growth.